Literature DB >> 12873854

Association study of Parkin gene polymorphisms with idiopathic Parkinson disease.

Sofia A Oliveira1, William K Scott, Martha A Nance, Ray L Watts, Jean P Hubble, William C Koller, Kelly E Lyons, Rajesh Pahwa, Matthew B Stern, Bradley C Hiner, Joseph Jankovic, William G Ondo, Fred H Allen, Burton L Scott, Christopher G Goetz, Gary W Small, Frank L Mastaglia, Jeffrey M Stajich, Fengyu Zhang, Michael W Booze, Joshua A Reaves, Lefkos T Middleton, Jonathan L Haines, Margaret A Pericak-Vance, Jeffery M Vance, Eden R Martin.   

Abstract

BACKGROUND: Previously, we detected linkage of idiopathic Parkinson disease (PD) to the region on chromosome 6 that contains the Parkin gene (D6S305; logarithm of odds score, 5.47) in families with at least one individual with age at onset younger than 40 years (families with early-onset disease). Further study demonstrated the presence of Parkin mutations in this data set. However, previous case-control studies have reported conflicting results regarding the role of more common Parkin polymorphisms as susceptibility alleles for idiopathic PD.
OBJECTIVE: To investigate the association of 7 previously studied Parkin single-nucleotide polymorphisms (SNPs) throughout the promoter and most of the open reading frame with PD in a large cohort of patients with primarily late-onset PD.
METHODS: One promoter, 3 intronic, and 3 exonic Parkin SNPs were genotyped in 1580 individuals belonging to 397 families, and their association with PD was evaluated using family-based association tests.
RESULTS: No significant association (P>.05) between PD and any Parkin SNP allele or genotype was detected. Haplotype analysis and stratification by age at onset or family history also failed to produce significant results.
CONCLUSIONS: These results suggest that these common variants of Parkin are not associated with PD in white patients, although Parkin mutations are known to cause early- and late-onset PD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12873854     DOI: 10.1001/archneur.60.7.975

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  18 in total

1.  Impaired transcriptional upregulation of Parkin promoter variant under oxidative stress and proteasomal inhibition: clinical association.

Authors:  E K Tan; K Y Puong; D K Y Chan; K Yew; S Fook-Chong; H Shen; P W Ng; J Woo; Y Yuen; R Pavanni; M C Wong; K Puvan; Y Zhao
Journal:  Hum Genet       Date:  2005-10-22       Impact factor: 4.132

2.  Lack of evidence for association of Parkin promoter polymorphism (PRKN-258) with increased risk of Parkinson's disease.

Authors:  Owen A Ross; Kristoffer Haugarvoll; Jeremy T Stone; Michael G Heckman; Linda R White; Jan O Aasly; J Mark Gibson; Timothy Lynch; Zbigniew K Wszolek; Ryan J Uitti; Matthew J Farrer
Journal:  Parkinsonism Relat Disord       Date:  2007-04-02       Impact factor: 4.891

Review 3.  Advances in the discovery of genetic risk factors for complex forms of neurodegenerative disorders: contemporary approaches, success, challenges and prospects.

Authors:  Sumeet Kumar; Navneesh Yadav; Sanjay Pandey; B K Thelma
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

Review 4.  Twenty years since the discovery of the parkin gene.

Authors:  Nobutaka Hattori; Yoshikuni Mizuno
Journal:  J Neural Transm (Vienna)       Date:  2017-06-15       Impact factor: 3.575

5.  Parsing the genetic heterogeneity of chromosome 12q susceptibility genes for Alzheimer disease by family-based association analysis.

Authors:  Ping-I Lin; Eden R Martin; Carrie A Browning-Large; Donald E Schmechel; Kathleen A Welsh-Bohmer; P Murali Doraiswamy; John R Gilbert; Jonathan L Haines; Margaret A Pericak-Vance
Journal:  Neurogenetics       Date:  2006-06-13       Impact factor: 2.660

6.  Manganese-induced toxicity in normal and human B lymphocyte cell lines containing a homozygous mutation in parkin.

Authors:  Jerome A Roth; Balakrishnan Ganapathy; Andrew J Ghio
Journal:  Toxicol In Vitro       Date:  2012-07-26       Impact factor: 3.500

7.  Examination of association of genes in the serotonin system to autism.

Authors:  B M Anderson; N C Schnetz-Boutaud; J Bartlett; A M Wotawa; H H Wright; R K Abramson; M L Cuccaro; J R Gilbert; M A Pericak-Vance; J L Haines
Journal:  Neurogenetics       Date:  2009-01-28       Impact factor: 2.660

Review 8.  Genetics of parkin-linked disease.

Authors:  Andrew B West; Nigel T Maidment
Journal:  Hum Genet       Date:  2004-01-15       Impact factor: 4.132

9.  Linkage disequilibrium and haplotype tagging polymorphisms in the Tau H1 haplotype.

Authors:  Sofia A Oliveira; William K Scott; Fengyu Zhang; Jeffrey M Stajich; Kenichiro Fujiwara; Michael Hauser; Burton L Scott; Margaret A Pericak-Vance; Jeffery M Vance; Eden R Martin
Journal:  Neurogenetics       Date:  2004-06-08       Impact factor: 2.660

10.  Comprehensive association analysis of APOE regulatory region polymorphisms in Alzheimer disease.

Authors:  Kristin K Nicodemus; Judith E Stenger; Donald E Schmechel; Kathleen A Welsh-Bohmer; Ann M Saunders; Allen D Roses; John R Gilbert; Jeffery M Vance; Jonathan L Haines; Margaret A Pericak-Vance; Eden R Martin
Journal:  Neurogenetics       Date:  2004-09-29       Impact factor: 2.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.